155 related articles for article (PubMed ID: 24988889)
21. Functional analysis of active urethral closure mechanisms under sneeze induced stress condition in a rat model of birth trauma.
Kamo I; Kaiho Y; Canon TW; Chancellor MB; de Groat WC; Prantil RL; Vorp DA; Yoshimura N
J Urol; 2006 Dec; 176(6 Pt 1):2711-5. PubMed ID: 17085201
[TBL] [Abstract][Full Text] [Related]
22. Urethral dysfunction and therapeutic effects of a PDE 5 inhibitor (tadalafil) in a rat model of detrusor underactivity induced by pelvic nerve crush injury.
Takaoka EI; Kurobe M; Suzuki T; Shimizu N; Kwon J; Okada H; Yoshimura N; Chermansky CJ
Neurourol Urodyn; 2020 Mar; 39(3):916-925. PubMed ID: 32040866
[TBL] [Abstract][Full Text] [Related]
23. Therapeutic effects of IGF-1 on stress urinary incontinence in rats with simulated childbirth trauma.
Sumino Y; Yoshikawa S; Mimata H; Yoshimura N
J Urol; 2014 Feb; 191(2):529-38. PubMed ID: 24036237
[TBL] [Abstract][Full Text] [Related]
24. Effect of a 5-HT2c receptor agonist on urethral closure mechanisms in female rats.
Ouchi M; Kitta T; Kanno Y; Higuchi M; Togo M; Moriya K; Shinohara N
Neurourol Urodyn; 2018 Nov; 37(8):2382-2388. PubMed ID: 29624732
[TBL] [Abstract][Full Text] [Related]
25. Strain-dependent urethral response.
Haworth DJ; Kitta T; Morelli B; Chew DW; Yoshimura N; de Groat WC; Vorp DA
Neurourol Urodyn; 2011 Nov; 30(8):1652-8. PubMed ID: 21826722
[TBL] [Abstract][Full Text] [Related]
26. Controlled release of insulin-like growth factor 1 enhances urethral sphincter function and histological structure in the treatment of female stress urinary incontinence in a rat model.
Yan H; Zhong L; Jiang Y; Yang J; Deng J; Wei S; Opara E; Atala A; Mao X; Damaser MS; Zhang Y
BJU Int; 2018 Feb; 121(2):301-312. PubMed ID: 28805303
[TBL] [Abstract][Full Text] [Related]
27. Neurophysiology and therapeutic receptor targets for stress urinary incontinence.
Yoshimura N; Miyazato M
Int J Urol; 2012 Jun; 19(6):524-37. PubMed ID: 22404481
[TBL] [Abstract][Full Text] [Related]
28. Combination histamine and serotonin treatment after simulated childbirth injury improves stress urinary incontinence.
Song QX; Balog BM; Lin DL; Jiang HH; Gurel V; Spaulding J; Tobacyk J; McMichael J; Damaser MS
Neurourol Urodyn; 2016 Aug; 35(6):703-10. PubMed ID: 26088829
[TBL] [Abstract][Full Text] [Related]
29. Therapeutic potential of muscle growth promoters in a stress urinary incontinence model.
Yang J; Balog B; Deng K; Hanzlicek B; Rietsch A; Kuang M; Hatakeyama S; Lach-Trifilieff E; Zhu H; Damaser MS
Am J Physiol Renal Physiol; 2020 Sep; 319(3):F436-F446. PubMed ID: 32686522
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of combined therapeutic effects of hydrogen sulfide donor sodium hydrogen sulfide and phosphodiesterase type-5 inhibitor tadalafil on erectile dysfunction in a partially bladder outlet obstructed rat model.
Yilmaz-Oral D; Kaya-Sezginer E; Oztekin CV; Bayatli N; Lokman U; Gur S
Neurourol Urodyn; 2020 Apr; 39(4):1087-1097. PubMed ID: 32150290
[TBL] [Abstract][Full Text] [Related]
31. Methods of testing urethral resistance in the female rat.
Damaser MS; Kim FJ; Minetti GM
Adv Exp Med Biol; 2003; 539(Pt B):831-9. PubMed ID: 15176326
[TBL] [Abstract][Full Text] [Related]
32. TAS-303, a Novel Selective Norepinephrine Reuptake Inhibitor that Increases Urethral Pressure in Rats, Indicating Its Potential as a Therapeutic Agent for Stress Urinary Incontinence.
Mizutani H; Sakakibara F; Komuro M; Sasaki E
J Pharmacol Exp Ther; 2018 Aug; 366(2):322-331. PubMed ID: 29875227
[TBL] [Abstract][Full Text] [Related]
33. Comparison of leak point pressure methods in an animal model of stress urinary incontinence.
Conway DA; Kamo I; Yoshimura N; Chancellor MB; Cannon TW
Int Urogynecol J Pelvic Floor Dysfunct; 2005; 16(5):359-63. PubMed ID: 16132162
[TBL] [Abstract][Full Text] [Related]
34. An investigation of the effects of zaprinast, a PDE inhibitor, on the nitrergic control of the urethra in anaesthetized female rats.
Wibberley A; Nunn PA; Naylor AM; Ramage AG
Br J Pharmacol; 2002 Jun; 136(3):399-414. PubMed ID: 12023943
[TBL] [Abstract][Full Text] [Related]
35. IGF-1 as an Important Endogenous Growth Factor for Recovery from Impaired Urethral Continence Function in Rats with Simulated Childbirth Injury.
Sumino Y; Yoshikawa S; Mori K; Mimata H; Yoshimura N
J Urol; 2016 Jun; 195(6):1927-35. PubMed ID: 26767520
[TBL] [Abstract][Full Text] [Related]
36. Single-dose Tadalafil Reduces Opening Urethral Pressure: A Randomized, Double-blind, Placebo-controlled, Crossover Trial in Healthy Women.
Christoffersen T; Riis T; Sonne DP; Klarskov N
Int Urogynecol J; 2024 Mar; 35(3):723-729. PubMed ID: 38456894
[TBL] [Abstract][Full Text] [Related]
37. The role of bladder-to-urethral reflexes in urinary continence mechanisms in rats.
Kamo I; Cannon TW; Conway DA; Torimoto K; Chancellor MB; de Groat WC; Yoshimura N
Am J Physiol Renal Physiol; 2004 Sep; 287(3):F434-41. PubMed ID: 15113743
[TBL] [Abstract][Full Text] [Related]
38. Effects of an alpha1A/D-adrenoceptor antagonist, naftopidil, and a phosphodiesterase type 5 inhibitor, tadalafil, on urinary bladder remodeling in rats with spinal cord injury.
Kadekawa K; Majima T; Kawamorita N; Okada H; Yoshizawa T; Mori K; Tyagi P; Sugaya K; Yoshimura N
Neurourol Urodyn; 2017 Aug; 36(6):1488-1495. PubMed ID: 27701772
[TBL] [Abstract][Full Text] [Related]
39. Effects of vaginal distension on urethral anatomy and function.
Cannon TW; Wojcik EM; Ferguson CL; Saraga S; Thomas C; Damaser MS
BJU Int; 2002 Sep; 90(4):403-7. PubMed ID: 12175397
[TBL] [Abstract][Full Text] [Related]
40. Tadalafil enhances the inhibitory effects of tamsulosin on neurogenic contractions of human prostate and bladder neck.
Angulo J; Cuevas P; Fernández A; La Fuente JM; Allona A; Moncada I; Sáenz de Tejada I
J Sex Med; 2012 Sep; 9(9):2293-306. PubMed ID: 22759598
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
